Pulmonary arterial hypertension in adults: novel drugs and catheter ablation techniques show promise? Systematic review on pharmacotherapy and interventional strategies. (Q33810499)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pulmonary arterial hypertension in adults: novel drugs and catheter ablation techniques show promise? Systematic review on pharmacotherapy and interventional strategies.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

2 references

3 February 2021

16 September 2022

Pulmonary arterial hypertension in adults: novel drugs and catheter ablation techniques show promise? Systematic review on pharmacotherapy and interventional strategies (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

catheterization

0 references

pharmacotherapy

0 references

catheter ablation

1 reference

3 February 2021

pulmonary hypertension

3 references

22 March 2019

25 June 2019

10 October 2019

circulatory system

1 reference

10 October 2019

Salvatore Rosanio

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Francesco Pelliccia

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Carlo Gaudio

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Cesare Greco

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Abdul M Keylani

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Darrin C D'Agostino

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

0 references

publication date

12 June 2014

6 references

22 March 2019

25 June 2019

10 October 2019

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

3 February 2021

16 September 2022

BioMed Research International

6 references

22 March 2019

25 June 2019

10 October 2019

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

3 February 2021

16 September 2022

2014

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

743868

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

copyright license

Creative Commons Attribution 3.0 Unported

5 references

Europe PubMed Central

22 March 2019

Europe PubMed Central

25 June 2019

Europe PubMed Central

10 October 2019

Europe PubMed Central

3 February 2021

Europe PubMed Central

16 September 2022

copyright status

0 references

0 references

on focus list of Wikimedia project

0 references

Riociguat for the treatment of pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Combination therapy improves exercise capacity and reduces risk of clinical worsening in patients with pulmonary arterial hypertension: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Targeting RhoA/ROCK pathway in pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Fasudil inhibits platelet-derived growth factor-induced human pulmonary artery smooth muscle cell proliferation by up-regulation of p27kip¹ via the ERK signal pathway.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Molecular and cellular bases of chronic myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

A decade of tyrosine kinase inhibitor therapy: Historical and current perspectives on targeted therapy for GIST.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

The use of combination therapy in pulmonary arterial hypertension: new developments.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Changing paradigm of the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Pulmonary arterial hypertension in France: results from a national registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Sildenafil citrate therapy for pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Reversal of experimental pulmonary hypertension by PDGF inhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Interventional and surgical modalities of treatment for pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Cellular and molecular pathobiology of pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

The endothelin system in pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Prostanoids for pulmonary arterial hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Inhaled iloprost for severe pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Isolation of putative progenitor endothelial cells for angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

VIP inhibits basal and histamine-stimulated proliferation of human airway smooth muscle cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Experimental pulmonary hypertension produced by surgical and chemical denervation of the pulmonary vasculature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Pulmonary vasoconstriction due to nonocclusive distention of large pulmonary arteries in the dog.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

Acute Pulmonary Artery Hypertension Produced by Distention of the Main Pulmonary Artery in the Conscious Dog

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

4 July 2018

An epidemiological study of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Updated Clinical Classification of Pulmonary Hypertension

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

REFLEX VASOMOTOR ACTIVITY DURING UNILATERAL OCCLUSION OF THE PULMONARY ARTERY.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Macitentan and morbidity and mortality in pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Tadalafil therapy for pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Differential effects of Selexipag [corrected] and prostacyclin analogs in rat pulmonary artery

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Pro-apoptotic effects of imatinib on PDGF-stimulated pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Role of Rho-kinase signaling and endothelial dysfunction in modulating blood flow distribution in pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

The effects of vasoactive intestinal peptide on monocrotaline induced pulmonary hypertensive rabbits following cardiopulmonary bypass: a comparative study with isoproteronol and nitroglycerine

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

New treatment strategies for pulmonary arterial hypertension: hopes or hypes?

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4072027

30 October 2018

Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Pulmonary Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F743868

21 January 2018

Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vasoactive intestinal peptide in pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atrial septostomy in patients with end-stage pulmonary hypertension. No more needles but wires, energy and close anatomical definition

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reflex Changes on the Pulmonary and Systemic Pressures Elicited by Stimulation of Baroreceptors in the Pulmonary Artery

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting tyrosine kinases in cancer: the second wave

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The vasoactive intestinal peptide receptor turnover in pulmonary arteries indicates an important role for VIP in the rat lung circulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2-[4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhalation of vasoactive intestinal peptide in pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25013799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2014/743868

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013799%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33810499&oldid=1729744226"